Cable Hill Partners’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q2
Sell
-67
Closed -$7K 767
2015
Q1
$7K Buy
+67
New +$7K 0.01% 520